Steven Cohen Immunome Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Immunome Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 385,067 shares of IMNM stock, worth $5.13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
385,067
Previous 385,067
-0.0%
Holding current value
$5.13 Million
Previous $4.66 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding IMNM
# of Institutions
118Shares Held
43.7MCall Options Held
67.2KPut Options Held
65.9K-
Redmile Group, LLC San Francisco, CA4.89MShares$65.1 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$51.7 Million1.66% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$51.7 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$50.1 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.16MShares$42.1 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $162M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...